• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Hologic readies mid-range 4500 scanner

Article

Like other bone densitometry vendors, Hologic is enjoying a banneryear, thanks to momentum created by Merck's Fosamax drug for thetreatment of osteoporosis. In addition to overall market growth,Hologic, of Waltham, MA, claims to have increased its market

Like other bone densitometry vendors, Hologic is enjoying a banneryear, thanks to momentum created by Merck's Fosamax drug for thetreatment of osteoporosis. In addition to overall market growth,Hologic, of Waltham, MA, claims to have increased its market sharein the segment to around 58%, compared with about 45% a year ago.

Hologic will try to build on its success by introducing a newmid-range member of its 4500 dual-energy x-ray absorptiometryfamily of bone measurement devices, according to Wade Fox, directorof marketing. Hologic developed the new system based on feedbackfrom clinicians, Fox said.

Hologic will also show its Sahara waterless ultrasound densitometer,which is not yet available in the U.S., as well as the mini C-armproduct line the company acquired through its purchase of Fluoroscanin August, Fox said.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.